Finance

Lists
Why is CNSP down 4,62%?
Dive Deeper
CNSP:NASDAQ
CNS Pharmaceuticals Inc
3,92 $
-4,62%
(-0,19) 1D
6 նոյ, 16:00:00 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CNSP...
Open
4,05 $
High
4,26 $
Low
3,89 $
Mkt. cap
5,73 մլն
Avg. vol.
12,31 հզր
Volume
8,42 հզր
52-wk high
10,54 $
52-wk low
1,90 $
EPS
-23,14 $
Beta
1,01
Shares outstanding
1,46 մլն
No. of employees
8
Open
4,05 $
High
4,26 $
Low
3,89 $
Mkt. cap
5,73 մլն
Avg. vol.
12,31 հզր
Volume
8,42 հզր
52-wk high
10,54 $
52-wk low
1,90 $
EPS
-23,14 $
Beta
1,01
Shares outstanding
1,46 մլն
No. of employees
8
News stories
From web sources and news partners
About CNS Pharmaceuticals Inc
CEO-
Employees8
Founded2017
HeadquartersՀյուստոն, Տեխաս, Միացյալ Նահանգներ
SectorHealth Care
Industry-
Websitecnspharma.com
Analyst
Recommendation
Action
Price target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Maintained
10,00 $
+155,1%
05/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2,20 մլն
3,17 մլն
3,54 մլն
1,20 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,06 մլն
2,82 մլն
1,43 մլն
1,50 մլն
Operating expense
3,25 մլն
5,99 մլն
4,98 մլն
2,70 մլն
Total operating expenses
3,25 մլն
5,99 մլն
4,98 մլն
2,70 մլն
Operating income
-3,25 մլն
-5,99 մլն
-4,98 մլն
-2,70 մլն
Other non operating income
-
-2,56 հզր
-
-
EBT including unusual items
-3,22 մլն
-5,96 մլն
-4,94 մլն
-2,59 մլն
EBT excluding unusual items
-3,22 մլն
-5,96 մլն
-4,94 մլն
-2,59 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3,22 մլն
-5,96 մլն
-4,94 մլն
-2,59 մլն
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
37,02 հզր
35,60 հզր
44,27 հզր
116,00 հզր
Interest expense
-2,12 հզր
-2,72 հզր
-6,11 հզր
-4,00 հզր
Net interest expenses
34,91 հզր
32,88 հզր
38,16 հզր
112,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-3,25 մլն
-5,99 մլն
-4,97 մլն
-2,69 մլն
Gain or loss from assets sale
-
2,56 հզր
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps